XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses:    
Research and development $ 3,293,861 $ 2,619,805
General and administrative 1,717,585 3,064,645
Total operating expenses 5,011,446 5,684,450
Loss from operations (5,011,446) (5,684,450)
Other income (expense):    
Investment income, net 81,921 253,070
Interest expense on loan facility (159,985)
Total other income (expense), net 81,921 93,085
Net loss $ (4,929,525) $ (5,591,365)
Weighted average shares outstanding - Basic 9,399,831 8,281,483
Weighted average shares outstanding - Diluted 9,399,831 8,281,483
Net loss per common share    
Net loss per common share - Basic $ (0.52) $ (0.68)
Net loss per common share - Diluted $ (0.52) $ (0.68)